WO2011077674A1 - ハイドロゲル粒子 - Google Patents
ハイドロゲル粒子 Download PDFInfo
- Publication number
- WO2011077674A1 WO2011077674A1 PCT/JP2010/007306 JP2010007306W WO2011077674A1 WO 2011077674 A1 WO2011077674 A1 WO 2011077674A1 JP 2010007306 W JP2010007306 W JP 2010007306W WO 2011077674 A1 WO2011077674 A1 WO 2011077674A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- organic
- hydrogel particles
- value
- solid fat
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 118
- 239000000017 hydrogel Substances 0.000 title claims abstract description 115
- 239000007787 solid Substances 0.000 claims abstract description 65
- 238000010586 diagram Methods 0.000 claims abstract description 14
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 52
- 239000002537 cosmetic Substances 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- -1 fatty acid glycerin esters Chemical class 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 18
- 230000001681 protective effect Effects 0.000 claims description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 239000000499 gel Substances 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 238000001879 gelation Methods 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000006096 absorbing agent Substances 0.000 abstract description 6
- 239000012071 phase Substances 0.000 description 74
- 239000000306 component Substances 0.000 description 66
- 239000007788 liquid Substances 0.000 description 62
- 239000003925 fat Substances 0.000 description 52
- 230000000052 comparative effect Effects 0.000 description 31
- 239000003921 oil Substances 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 29
- 239000006185 dispersion Substances 0.000 description 23
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 18
- 239000002270 dispersing agent Substances 0.000 description 18
- 230000001804 emulsifying effect Effects 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000013078 crystal Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 7
- 230000006750 UV protection Effects 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000002736 nonionic surfactant Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000000975 dye Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 4
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 3
- DKLGGNTZHFDTAY-UHFFFAOYSA-N C(CC)(=O)O.C(CCCCCCC)C(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC Chemical compound C(CC)(=O)O.C(CCCCCCC)C(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC DKLGGNTZHFDTAY-UHFFFAOYSA-N 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- HJJZFSVYWJHHFE-UHFFFAOYSA-N docosanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCCCCCCCCCCCC(O)=O HJJZFSVYWJHHFE-UHFFFAOYSA-N 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- 229940093625 propylene glycol monostearate Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 239000007863 gel particle Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000005518 polymer electrolyte Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000000790 scattering method Methods 0.000 description 2
- 235000002316 solid fats Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BOCBOJPUWMTAJB-UHFFFAOYSA-N (2-butylphenyl) 2-hydroxybenzoate Chemical compound CCCCC1=CC=CC=C1OC(=O)C1=CC=CC=C1O BOCBOJPUWMTAJB-UHFFFAOYSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- OWQPOVKKUWUEKE-UHFFFAOYSA-N 1,2,3-benzotriazine Chemical compound N1=NN=CC2=CC=CC=C21 OWQPOVKKUWUEKE-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- AUZVIRWBLBNRSM-UHFFFAOYSA-N 2-benzylidene-1,3-dimethoxyimidazolidine-4,5-dione;propanoic acid Chemical compound CCC(O)=O.CON1C(=O)C(=O)N(OC)C1=CC1=CC=CC=C1 AUZVIRWBLBNRSM-UHFFFAOYSA-N 0.000 description 1
- OSJVRHJQUTTZIN-UHFFFAOYSA-N 2-ethoxyethyl 2-methoxy-3-phenylprop-2-enoate Chemical compound CCOCCOC(=O)C(OC)=CC1=CC=CC=C1 OSJVRHJQUTTZIN-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- KLPCZNSIPDGAJJ-UHFFFAOYSA-N 2-methoxy-3,3-dimethyl-1-phenylbutan-1-one Chemical compound COC(C(C)(C)C)C(=O)C1=CC=CC=C1 KLPCZNSIPDGAJJ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000007600 charging Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940081141 hexadecanamide Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- LZXXNPOYQCLXRS-UHFFFAOYSA-N methyl 4-aminobenzoate Chemical compound COC(=O)C1=CC=C(N)C=C1 LZXXNPOYQCLXRS-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- KHWYIJAORSAUBD-UHFFFAOYSA-N n-[2-(2,3-dihydroxypropoxy)-3-hexadecoxypropyl]-n-(3-methoxypropyl)tetradecanamide Chemical compound CCCCCCCCCCCCCCCCOCC(OCC(O)CO)CN(CCCOC)C(=O)CCCCCCCCCCCCC KHWYIJAORSAUBD-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- UPHWVVKYDQHTCF-UHFFFAOYSA-N octadecylazanium;acetate Chemical compound CC(O)=O.CCCCCCCCCCCCCCCCCCN UPHWVVKYDQHTCF-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000012801 ultraviolet ray absorbent Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 239000000984 vat dye Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
- B01J13/0065—Preparation of gels containing an organic phase
Definitions
- the present invention relates to hydrogel particles and a method for producing the same.
- Patent Document 1 discloses a skin cosmetic in which hydrogel particles containing an oily component are dispersed in an aqueous medium.
- JP 2002-159838 A Japanese Patent Laid-Open No. 2002-20227
- the present invention includes a continuous phase of a non-crosslinked hydrogel and a dispersed phase dispersed in the continuous phase, and the dispersed phase has an organic value of 310 or more and an inorganic value of 130 or more in an organic conceptual diagram.
- a solid fat and a crystalline organic ultraviolet absorber are contained, and the crystalline organic ultraviolet absorber is a hydrogel particle having a content of 15 to 70% by mass in the dispersed phase.
- the present invention provides a mixture comprising a crystalline organic ultraviolet absorber, a solid fat having an organic value of 310 or more and an inorganic value of 130 or more in an organic conceptual diagram, a gel-forming agent, and water.
- a crystalline organic ultraviolet absorber a solid fat having an organic value of 310 or more and an inorganic value of 130 or more in an organic conceptual diagram
- a gel-forming agent a gel-forming agent
- water water
- the hydrogel particles in which the dispersed phase containing the crystalline organic ultraviolet absorber and the solid fat is dispersed in the continuous phase of the gel-forming agent and the water-containing non-crosslinked hydrogel by stirring is prepared so that the content of the crystalline organic ultraviolet absorber in the dispersed phase of the hydrogel particles to be produced is 15 to 70% by mass.
- the present invention is an ultraviolet protective cosmetic containing the hydrogel particles of the present invention.
- the hydrogel particles according to the present embodiment are used, for example, in cosmetics, pharmaceuticals, quasi drugs, and the like, and include a continuous phase of a non-crosslinked hydrogel and a dispersed phase dispersed in the continuous phase.
- the dispersed phase contains a solid fat having an organic value (OV) of 310 or more and an inorganic value (IV) of 130 or more in the organic conceptual diagram, and a crystalline organic ultraviolet absorber,
- the content of the crystalline organic ultraviolet absorber in the dispersed phase is 15 to 70% by mass.
- Crystalline organic UV absorbers are used in cosmetics, etc., but have low solubility in various oils and solvents that are commonly used in cosmetics. Therefore, they are stably incorporated into cosmetics. It is difficult to do.
- the crystalline organic ultraviolet absorber when blended in the hydrogel particles, the crystalline organic ultraviolet absorber is hardly soluble in the oil component, and the crystalline organic ultraviolet absorber is dissolved in the oil component.
- crystals When used in such a manner, crystals are likely to precipitate in the solution at the time of storage, and thus there are problems such as a low degree of freedom in formulation design and a decrease in ultraviolet absorption ability.
- the crystalline organic ultraviolet absorber is blended in a high concentration of 15 to 70% by mass in the dispersed phase due to having the above-described configuration. Crystallization of the crystalline organic ultraviolet absorber at the time can be suppressed.
- hydrogel particles in the present application are one or a plurality of particles in which a dispersed phase is dispersed in a continuous phase of a non-crosslinked hydrogel, which includes an inner layer core component and an outer layer. Capsules that are concentrically arranged with the outer skin are not included.
- hydrogel in the present application refers to a gel obtained from a gel forming agent using water as a solvent.
- the structure in which the dispersed phase is dispersed in the continuous phase in the hydrogel particles can be confirmed by, for example, photographic observation analysis using a frozen cleaving SEM.
- the volume-based average particle size of the hydrogel particles is preferably 10 to 10,000 ⁇ m, more preferably 10 to 5000 ⁇ m, still more preferably 30 to 3000 ⁇ m, and more preferably 60 to 500 ⁇ m from the viewpoint of appearance and productivity. More preferably, it is particularly preferably 60 to 250 ⁇ m.
- the volume-based average particle diameter of the hydrogel particles can be measured by a laser diffraction scattering method (for example, a model number manufactured by Horiba, Ltd .: LA-920) or a sieving method.
- the laser diffraction / scattering method is preferably used for measuring particles of 1000 ⁇ m or less, and the screening method is preferably used for measuring particles exceeding 1000 ⁇ m.
- the shape of the hydrogel particles is not particularly limited, but is preferably a shape of a rotating body constituted by a curved surface.
- the “rotary body constituted by a curved surface” means a closed figure constituted by a virtual axis and a continuous curve, rotated by the virtual axis, and has a shape such as a triangular pyramid or a cylinder. Is not included.
- the shape of the hydrogel particles is more preferably spherical or elliptical from the viewpoint of aesthetics.
- the continuous phase is composed of a non-crosslinked hydrogel of an aqueous component, and includes a gel forming agent and water.
- the content of the continuous phase in the hydrogel particles is preferably 20 to 99% by mass, preferably 25 to 85% by mass, from the viewpoint of preventing disintegration when the hydrogel particles are washed and blended into cosmetics. More preferably, it is more preferably 30 to 80% by mass.
- non-crosslinked hydrogel refers to a gel that undergoes gelation due to thermoreversibility of the sol-gel.
- the dissolution temperature of the non-crosslinked hydrogel in water is generally preferably 75 ° C. or higher, more preferably 75 to 90 ° C., and the gelation temperature when cooled after being dissolved in water is 30. A temperature of ⁇ 45 ° C. is preferable.
- Jelly strength of non-crosslinked hydrogel is preferably from 147kPa (1500g / cm 2), 19.6kPa (200g / cm 2) ⁇ More preferably, it is 127 kPa (1300 g / cm 2 ).
- the jelly strength can be determined by the Nissho water method. Specifically, the jelly strength is determined by preparing a 1.5% by weight aqueous solution of a gel forming agent, and allowing the aqueous solution to stand for 15 hours at 20 ° C. to solidify the gel. The maximum mass (g) per 1 cm 2 of the surface area when the gel withstands the load at 20 ° C. for 20 seconds at 20 ° C. can be obtained.
- ⁇ Gel forming agent examples include agar, carrageenan, gelatin and the like. Of these, agar is preferred.
- the gel forming agent may be composed of a single species or a plurality of species.
- the content of the gel-forming agent in the continuous phase is good when used when applied to cosmetics, etc., from the viewpoint of preventing disintegration during washing of hydrogel particles and blending into cosmetics, etc. It is preferably 0.1% by mass or more, more preferably 0.3% by mass or more, further preferably 0.4% by mass or more, and particularly preferably 0.5% by mass or more. preferable.
- the content of the gel-forming agent in the hydrogel particles is good when used when applied to cosmetics, etc., and prevents collapse when the hydrogel particles are washed and blended into cosmetics. In view of the above, it is preferably 8.0% by mass or less, more preferably 7.0% by mass or less, still more preferably 6.0% by mass or less, and 5.0% by mass or less. It is particularly preferred.
- the dispersed phase contains an oily component containing solid fat and a crystalline organic ultraviolet absorber.
- the content of the dispersed phase in the hydrogel particles is preferably 1 to 70% by mass, preferably 7.5 to 70% by mass from the viewpoint of preventing breakage when the hydrogel particles are washed and blended into cosmetics. %, More preferably 10 to 70% by mass, still more preferably 15 to 60% by mass, and particularly preferably 20 to 50% by mass.
- the volume-based average particle diameter of the dispersed phase is preferably 1/10 or less of the volume-based average particle diameter of the hydrogel particles.
- the volume-based average particle diameter of the dispersed phase can be smoothly extended on the skin when applied to cosmetics, etc., and the dispersion phase leakage suppression from hydrogel particles, cosmetics, etc. From the viewpoint of good conformability to the skin when applied to the skin, it is preferably 0.01 to 100 ⁇ m, more preferably 0.5 to 50 ⁇ m, and more preferably 0.5 to 20 ⁇ m. Further preferred.
- the volume-based average particle size of the disperse phase is the state of the dispersion before particle formation, and the laser diffraction / scattering using a laser diffraction / scattering type particle size distribution measuring device (for example, model number: LA-920 manufactured by Horiba, Ltd.). It can be measured by the method.
- a laser diffraction / scattering type particle size distribution measuring device for example, model number: LA-920 manufactured by Horiba, Ltd.
- the oil component includes solid fat, but may be composed of only solid fat, or may include liquid oil.
- solid fat in the present application refers to an oily component having a melting point of 35 ° C. or higher.
- the “liquid oil” in the present application refers to an oily component having a melting point of less than 35 ° C.
- fusing point of solid fat or liquid oil can be measured by the differential scanning calorimetry (DSC: Differential Scanning Calorimentry).
- the content of the oil component in the dispersed phase is preferably 30 to 85% by mass, and preferably 30 to 80% by mass, from the viewpoint of good feel when used when applied to cosmetics and the like. More preferably, it is 30 to 65% by mass, still more preferably 40 to 60% by mass.
- the total content of oily components in the hydrogel particles has a good feel when used when applied to cosmetics, etc., and prevents collapse when hydrogel particles are washed and blended into cosmetics, etc. From this viewpoint, it is preferably 0.01 to 60% by mass, more preferably 3.0 to 50% by mass, further preferably 5.0 to 40% by mass, and 7.5 to 25%. It is particularly preferable that the content is% by mass.
- the melting point of the oily component is preferably 35 ° C. or more, more preferably 40 to 90 ° C., and more preferably 40 to 80 ° C. from the viewpoint of suppressing leakage of the oily component from the hydrogel particles during high temperature storage. More preferably.
- the melting point of the oil component can also be measured by differential scanning calorimetry.
- Solid fat A solid fat having an organic value (OV) of 310 or more and an inorganic value (IV) of 130 or more in the organic conceptual diagram.
- the “organic conceptual diagram” means that the covalent bondability of a compound is evaluated by an organic value (OV) and the ionic bondability is evaluated by an inorganic value (IV).
- the horizontal axis indicates the organic axis and the vertical axis. It is the figure which represented the positioning of the compound by the point (OV, IV) on the orthogonal coordinate plane made into the inorganic axis.
- the organic value (OV) is a value obtained by multiplying the number of carbon atoms of the compound by 20, and the inorganic value (IV) is a cumulative addition value of the inorganic value given to each substituent contained in the compound.
- inorganic values see “Organic Conceptual Diagram-Fundamentals and Applications” (author: Yoshio Koda, publisher: Sankyo Publishing, published in 1984) p. Reference can be made to 13 tables.
- the solid fat A has an organic value (OV) of 310 or more, preferably 330 or more, more preferably 350 or more, still more preferably 400 or more, and 1000 or less. Is preferable, and 800 or less is more preferable.
- the solid fat A has an inorganic value (IV) of 130 or more, preferably 140 or more, more preferably 150 or more, and preferably 800 or less, and 700 or less. More preferably, it is more preferably 500 or less.
- the solid fat A is preferably 11 ° ⁇ ⁇ ⁇ 48 °, and 13 ° ⁇ ⁇ ⁇ 48, where ⁇ is an angle between a straight line passing through the origin and the point (OV, IV) and the organic axis in the organic conceptual diagram. More preferably, it is 15 ° ⁇ ⁇ ⁇ 47 °.
- solid fat A examples include fatty acid glycerin esters, fatty acid alkylene glycol esters, and solid ceramide.
- fatty acid glycerin esters and fatty acid alkylene glycol esters are preferred.
- solid fat A a compound represented by the following general formula (1) can be suitably used.
- n is preferably a number of 1 to 2, and n is more preferably a number of 1.
- X is H, OH, or OCOR 2 is more preferable.
- Y is more preferably OH, OCOR 2 or OCO (CH 2 ) 2 COOH.
- Solid fat A may be composed of a single species or a plurality of species.
- the content of the solid fat A in the dispersed phase was applied to the viewpoint of stably blending the organic ultraviolet absorber having crystallinity, the viewpoint of suppressing the leakage of the oily component from the hydrogel particles, and cosmetics. From the viewpoint of ease of spreading on the skin in the case, it is preferably 1 to 85% by mass, more preferably 1 to 75% by mass, further preferably 3 to 70% by mass, and more preferably 5 to More preferably, it is 60 mass%.
- the total content of the solid fat A in the hydrogel particles is preferably 0.2 to 30% by mass, and more preferably 1.0 to 20% by mass.
- the melting point of the solid fat A is 35 ° C. or higher, but is preferably 40 to 120 ° C., more preferably 40 ° C. to 80 ° C. from the viewpoint of suppressing leakage of oily components from the hydrogel particles. preferable.
- the oil component may contain only the solid fat A as the solid fat, and other than the solid fat A as long as it does not inhibit the effect of suppressing the crystal precipitation of the crystalline organic ultraviolet absorber blended at a high concentration.
- Solid fat may be included. Examples of the solid fat other than the solid fat A include solid paraffin and higher alcohol.
- liquid oil examples include a liquid skin protectant, a liquid ultraviolet absorber, a liquid oil, and a liquid fragrance.
- liquid skin protectants include liquid oils such as liquid paraffin, liquid ester oil, liquid higher alcohol, liquid squalane and liquid glyceride; liquid ceramide such as cetyloxypropyl glyceryl methoxypropyl myristamide Is mentioned.
- liquid ultraviolet absorbers examples include paraaminobenzoic acid, methyl paraaminobenzoate, glyceryl paraaminobenzoate, amyl paradimethylaminobenzoate, octyl paradimethylaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, butylphenyl salicylate, Examples include homomenthyl salicylate, octyl paramethoxycinnamate, ethoxyethyl methoxycinnamate, glyceryl monoethylhexanoate, hydroxymethoxybenzophenone, dihydroxydimethoxybenzophenone, octyltriazone, and the like.
- liquid oils examples include liquid hydrocarbon oils, liquid vegetable oils, liquid fatty acids, etc .; liquid ethylene glycol difatty acid esters (fatty acid having 12 to 36 carbon atoms, branched or saturated hydrocarbon group) Liquid oils and fats such as liquid dialkyl ethers (fatty acid having 12 to 36 carbon atoms and branched saturated or unsaturated hydrocarbon group) having 12 to 36 carbon atoms; and liquid silicones.
- Liquid oil may be composed of a single species or a plurality of species.
- the content of the liquid oil in the dispersed phase is hardly soluble and has a crystallinity from the viewpoint of stably blending an organic ultraviolet absorber and from the viewpoint of ease of spreading on the skin when applied to cosmetics, etc.
- the content is preferably 0 to 75% by mass, more preferably 0 to 65% by mass, further preferably 0 to 60% by mass, and still more preferably 0 to 50% by mass.
- the total content of liquid oil in the hydrogel particles is preferably 0 to 25% by mass, and more preferably 0 to 20% by mass.
- crystalline means having a peak by X-ray diffraction and confirming the crystalline state.
- Organic ultraviolet absorber means a compound that exhibits the ability to absorb ultraviolet rays in the wavelength range of 280 to 400 nm, particularly UVA in the wavelength range of 320 to 400 nm, and does not contain inorganic substances such as titanium and zinc. The presence / absence of ultraviolet absorbing ability can be confirmed using an apparatus such as an SPF analyzer.
- the crystalline organic ultraviolet absorber may be composed of a single species or a plurality of species.
- the crystalline organic ultraviolet absorber preferably has an organic value (OV) of 310 to 800, more preferably 330 to 700, more preferably 350 to 600, and an inorganic value.
- (IV) is preferably from 130 to 700, more preferably from 150 to 600.
- the crystalline organic ultraviolet absorber preferably satisfies 0.30 ⁇ IOB value ⁇ 1.1, and more preferably satisfies 0.35 ⁇ IOB value ⁇ 1.00.
- the crystalline organic ultraviolet absorber preferably satisfies 3.0 ⁇ HLB value ⁇ 11, and more preferably satisfies 3.5 ⁇ HLB value ⁇ 10.0.
- the crystalline organic ultraviolet absorber preferably satisfies 16 ° ⁇ ⁇ ⁇ 48 °, where ⁇ is an angle between a straight line passing through the origin and the point (OV, IV) and the organic axis in the organic conceptual diagram, and 18 ° More preferably, ⁇ ⁇ ⁇ 48 °, and further preferably 21 ° ⁇ ⁇ ⁇ 47 °.
- the organic value (OV) of the crystalline organic ultraviolet absorber is preferably within ⁇ 250, more preferably within ⁇ 200, more preferably within ⁇ 150 of the organic value (OV) of the solid fat A. More preferably, it is particularly preferably within ⁇ 100, and the inorganic value (IV) of the crystalline organic ultraviolet absorber is within ⁇ 350 of the inorganic value (IV) of the solid fat A. Preferably, it is within ⁇ 300, more preferably within ⁇ 200, even more preferably within ⁇ 150, and particularly preferably within ⁇ 100.
- the content of the crystalline organic ultraviolet absorber in the dispersed phase is 15 to 70% by mass, preferably 20 to 70% by mass, more preferably 40 to 70% by mass from the viewpoint of UV protection ability. preferable.
- the content ratio of the crystalline organic ultraviolet absorbent in the dispersed phase to the solid fat A (the content of the crystalline organic ultraviolet absorbent in the dispersed phase / the content of the solid fat A in the dispersed phase) is 0.1 to 50 It is preferably 0.15 to 30, more preferably 0.2 to 15.
- the total content of the crystalline organic ultraviolet absorber in the hydrogel particles is preferably 3 to 50% by mass, more preferably 5 to 40% by mass, from the viewpoint of UV protection ability, and more preferably 10 to 30%. More preferably, it is mass%.
- the continuous phase is composed of water-soluble organic compounds such as sugars, polyhydric alcohols, water-soluble polymer compounds and water-soluble fragrances described in JP-A-2000-126586, in addition to the gelling agent for non-crosslinked hydrogel and water. You may contain a component.
- Each of the continuous phase and the dispersed phase may contain components such as an emulsifying dispersant, a colorant, and a preservative described later.
- the colorant include pigments and dyes.
- the pigment include inorganic pigments such as carbon black, bengara and titanium oxide, and organic pigments such as tar dyes.
- the dye include oil-soluble dyes, vat dyes, lake dyes, and the like.
- the preservative include methyl paraoxybenzoate, isopropylmethylphenol, dehydroacetic acid and salts thereof.
- each of the continuous phase and the dispersed phase may contain components such as a moisturizing agent, an antiperspirant, an antibacterial agent, a bactericidal agent and a powder applied to cosmetics, pharmaceuticals, quasi drugs and the like.
- an aqueous component gel-forming agent and ion-exchanged water are mixed as a continuous phase component solution, and heated to a temperature equal to or higher than the dissolution temperature to prepare a mixed solution A that is sufficiently dissolved.
- an oily component and a crystalline organic ultraviolet absorber are mixed by heating as a dispersed phase component liquid to prepare a mixed solution B in which it is sufficiently dissolved.
- the dispersed phase component liquid is prepared so that the content of the crystalline organic ultraviolet absorber in the dispersed phase of the produced hydrogel particles is 15 to 70% by mass.
- the continuous phase component liquid (mixed liquid A) and the dispersed phase component liquid (mixed liquid B) are mixed at a temperature equal to or higher than the gelation temperature to prepare an oil-in-water dispersion (mixture).
- the method for preparing the oil-in-water dispersion is not particularly limited, and known techniques using various stirrers, dispersers and the like can be applied.
- the oil-in-water dispersion is prepared so that the content of the crystalline organic ultraviolet absorber in the dispersed phase of the hydrogel particles to be produced is 15 to 70% by mass.
- emulsifying dispersant examples include a polymer emulsifying dispersant, a nonionic surfactant, an anionic surfactant, a cationic surfactant, and an amphoteric surfactant.
- a single type of emulsifying dispersant may be added, or a plurality of types may be added.
- emulsifying and dispersing agents from the viewpoint of ease of spreading on the skin when applied to cosmetics, etc., and from the viewpoint of good handling properties at the time of washing and blending into cosmetics, etc.
- An ionic surfactant, an anionic surfactant, a cationic surfactant, a combined use of an amphoteric surfactant and a polymer emulsifying dispersant, and a combined use of a nonionic surfactant and a polymer emulsifying dispersant are preferable, It is also preferable to use a polymer emulsifying dispersant alone.
- the addition of the surfactant can be reduced or eliminated, so that when applied to cosmetics, etc., stickiness due to the surfactant when applied to the skin Can be reduced.
- polymer emulsifying dispersant examples include, for example, acrylic acid / alkyl methacrylate copolymers, composites synthesized from amphoteric polymer compounds described in JP-A-7-100300 and higher fatty acids, JP-A-8- Water-soluble amphiphilic polymer electrolytes described in JP-A Nos. 252447 and 9-1441079, respectively, and water-soluble crosslinked parents described in JP-A Nos. 9-14080 and 9-148101, respectively.
- JP-A-10-330401 and JP-A-11-106401 Derivatives, polyvinylpyrrolidone, polyvinyl alcohol or derivatives thereof, polyacrylamide, alkylphenol Synthetic polymer compounds such as ethylene oxide adducts of Lumpur formaldehyde condensates, Guayagamu, karaya gum, tragacanth gum, gum arabic, arabinogalactan, natural polymer compounds such as casein.
- acrylic acid / alkyl methacrylate copolymers for example, trade name, manufactured by Nikko Chemicals, Inc.
- PEMULEN polyvinyl alcohol
- polyvinyl alcohol for example, Nippon Seikagaku Kagaku Kogyo brand name: Gohsenol, etc.
- polysaccharide derivatives described in Japanese Patent No. 3329689 are preferred.
- the polymer emulsifying dispersant may be neutralized, and after the addition, a pH adjusting agent such as potassium hydroxide or sodium hydroxide may be added. May be neutralized.
- the pH of the liquid after neutralization is preferably 4 to 8, and more preferably 6 to 7.
- anionic surfactant examples include sodium lauryl sulfate, sodium stearate, polyoxyethylene lauryl ether sodium phosphate, and the like.
- cationic surfactant examples include lauryltrimethylammonium chloride, stearylamine acetate, stearylamine acid and the like.
- the nonionic surfactant preferably has an HLB value of 10 or less, more preferably 8 or less. Preferably it is 5 or less, more preferably 3 or less.
- the HLB value can be obtained based on the calculation formula described in “Emulsification / Solubilization Technology” Engineering Book (Sho 59-5-20), pages 8-12.
- nonionic surfactants sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, from the viewpoint of low skin irritation when the produced hydrogel particles are applied to cosmetics, etc. Esters are preferred, and sorbitan monostearate is more preferred.
- those having a melting point of 35 ° C. or higher are preferable, and those having a temperature of 40 to 90 ° C. are more preferable from the viewpoint of suppressing leakage of oily components from the produced hydrogel particles. 50 to 90 ° C. is more preferable, and 60 to 80 ° C. is particularly preferable.
- amphoteric surfactants examples include alkyldimethylaminoacetic acid betaine and lecithin.
- hydrogel particles are produced from the oil-in-water dispersion by a general dropping method, spraying method, or stirring method.
- a dropping method or a spraying method rather than a stirring method.
- the dripping method uses the property that an oil-in-water dispersion is discharged from a hole, and the discharged oil-in-water dispersion becomes droplets due to its surface tension or interfacial tension.
- hydrogel particles are produced by cooling and solidifying in a liquid phase. From the viewpoint of producing hydrogel particles having a uniform particle diameter, it is preferable to vibrate the oil-in-water dispersion discharged from the holes.
- the spray method uses a spray nozzle, sprays the dispersion liquid into the gas phase from the spray nozzle, forms droplets by the surface tension, and cools the droplets in the gas phase to solidify them to produce hydrogel particles It is a method to do.
- the oil-in-water dispersion is introduced into a liquid having a property that does not substantially mix with the oil-in-water dispersion and adjusted to a temperature equal to or higher than the gelling temperature, and the oil-in-water type by shearing force by stirring.
- the temperature of the oil-in-water dispersion at the time of discharging, spraying, or charging is a temperature not lower than the gelling temperature and not higher than 100 ° C .
- the temperature of the oil-in-water dispersion is preferably set to a gelation temperature + 10 ° C. or higher, and a gelation temperature + 20 ° C. or higher. More preferably. The upper limit of this temperature is 100 ° C., which is the boiling point of water.
- the hydrogel particles produced as described above may be made into fine hydrogel particles by further pulverization or the like, if necessary.
- UV protective cosmetics By blending the above hydrogel particles, an ultraviolet protective cosmetic having an ultraviolet protective effect can be obtained.
- the present invention can be applied to both w / o type and o / w type cosmetics, but is preferably used for o / w type cosmetics.
- the content of the hydrogel particles in the ultraviolet protective cosmetic is preferably 5 to 80% by mass, more preferably 5 to 75% by mass, and further preferably 5 to 50% by mass.
- the ultraviolet ray absorbing effect can be further enhanced by further adding an organic ultraviolet ray absorbent to the ultraviolet ray protective cosmetic.
- the organic ultraviolet absorber used at this time is not particularly limited, and any oil-soluble or water-soluble one can be suitably used. For example, the one described in JP-A-2006-225311 is used. Can do.
- the oil-soluble organic ultraviolet absorber include benzoic acid, salicylic acid, cinnamic acid, benzophenone, benzoylmethane, triazine, and benzotriazine.
- the total content of the organic ultraviolet absorber in the ultraviolet protective cosmetic is preferably 1 to 35% by mass, more preferably 5 to 30% by mass, from the viewpoints of suppressing the stickiness of the skin and the ultraviolet absorption effect.
- the content is preferably 8 to 25% by mass.
- the UV protective cosmetic may contain an oil from the viewpoint of adjusting the feel.
- oil agents include oil agents described in JP-A-2006-225311, and ester oils and silicone oils are particularly preferable from the viewpoint of improving touch.
- the content of the oil agent in the ultraviolet protective cosmetic is preferably 0.1 to 15% by mass, and more preferably 0.1 to 10% by mass.
- the UV protective cosmetic may contain a surfactant (excluding a polymer emulsifying dispersant) from the viewpoint of improving the stability of the cosmetic.
- a surfactant include nonionic surfactants, anionic surfactants, cationic surfactants and amphoteric surfactants as described above.
- the content of the surfactant (excluding the surfactant present in the hydrogel particles) in the UV protective cosmetic is preferably 5% by mass or less from the viewpoint of obtaining a good feeling on the skin, It is more preferably 3% by mass or less, and further preferably 1% by mass or less.
- the ultraviolet protective cosmetics are within the range not impairing the effects of the present invention, polymer emulsifying dispersants, whitening agents, bactericides, antiperspirants, moisturizers, refreshing agents, fragrances, coloring agents, etc. May be blended.
- UV protection cosmetics can be applied to the skin to suppress the stickiness and bulkiness of the skin, and further to maintain these feelings so that active ingredients such as UV absorbers can remain on the skin for a long time.
- content in the obtained hydrogel particle might be 13.5 mass% of stearic acid monoglyceride and 13.5 mass% of diethylamino hydroxy benzoyl benzoate.
- the content of each component in the dispersed phase component liquid is 50% by mass of monoglyceride stearate and 50% by mass of hexyl diethylaminohydroxybenzoylbenzoate. That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 1.
- product name: Leodol MS-60 manufactured by Kao Corporation is a solid fat mainly composed of stearic acid monoglyceride.
- agar made by Ina Food Industry Co., Ltd., trade name: AX-200
- acrylic acid / alkyl methacrylate copolymer made by Nikko Chemicals, Inc., trade name: PEMULEN TR-2
- polyvinyl alcohol A continuous phase component solution containing a product name of Gosenol EG-05) manufactured by Synthetic Chemical Industry Co., Ltd., a 1N NaOH aqueous solution (manufactured by Kishida Chemical Co., Ltd.) as a pH adjuster, and ion exchange water was prepared.
- the content of the obtained hydrogel particles is 2.0% by mass of agar, 0.1% by mass of acrylic acid / alkyl methacrylate copolymer, 0.5% by mass of polyvinyl alcohol, and 0.75% by mass of 1N NaOH aqueous solution. %, And ion-exchanged water and other balances were added.
- a total of 1000 g of the dispersed phase component liquid and the continuous phase component liquid was prepared so as to have a mass ratio of 27:73, and the dispersed phase component liquid was heated and dissolved at 80 ° C. and the continuous phase component liquid was heated at 90 ° C., respectively. Thereafter, the dispersed-phase component liquid is added to the continuous-phase component liquid, and the mixture is stirred for 1 minute at a rotational speed of 8000 rpm using a homomixer (a product name of TK Robotics manufactured by Primics Co., Ltd.) for 1 minute to disperse in oil-in-water. A liquid was prepared.
- the temperature of the oil-in-water dispersion is maintained at 80 ° C., and the oil-in-water dispersion is tanked at a flow rate of 12 kg / hr at a height of 3.4 m from the spray nozzle (Ikeuchi Airborne Conical Nozzle K-010). It sprayed in the gas phase of 25 degreeC inside, and the hydrogel particle by which the droplet of the oil-in-water dispersion formed by spraying was solidified by cooling was collect
- This hydrogel particle was defined as Example 1.
- the composition of Example 1 was the same as that of Example 1 except that the content in the resulting hydrogel particles was 10.5% by mass of stearic acid monoglyceride and 3.0% by mass of stearic acid monoglyceride succinate. Hydrogel particles were prepared and designated as Example 4.
- the content of each component in the dispersed phase component liquid is 38.9% by mass of stearic acid monoglyceride, 11.1% by mass of stearic acid monoglyceride succinate, and 50% by mass of hexyl diethylaminohydroxybenzoylbenzoate. . That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 1.
- Example 5 While using stearic acid monoglyceride as the solid fat of the oil component and using octyl paramethoxycinnamate (trade name: Ubinal MC80 manufactured by BASF Japan Ltd.) as the liquid oil, the content in the resulting hydrogel particles is stearic acid monoglyceride 9 A hydrogel particle having the same structure as that of Example 1 was prepared, except that the blending was performed so that the content was 0.0% by mass and octyl paramethoxycinnamate was 4.5% by mass.
- the content of each component in the dispersed phase component liquid is 33.3% by mass of monoglyceride stearate, 16.7% by mass of octyl paramethoxycinnamate, and 50% by mass of hexyl diethylaminohydroxybenzoylbenzoate. . That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 1.5.
- Example 6 Hydro having the same structure as in Example 1 except that the content in the resulting hydrogel particles was 10.8% by mass of monoglyceride stearate and 16.2% by mass of hexyl diethylaminohydroxybenzoyl benzoate.
- a gel particle was prepared and used as Example 6.
- content in the dispersed phase component liquid of each component is 40 mass% of stearic acid monoglyceride, and 60 mass% of hexyl diethylaminohydroxybenzoyl benzoate. That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 1.5.
- the content of each component in the dispersed phase component liquid is 80% by mass for monoglyceride laurate and 20% by mass for hexyl diethylaminohydroxybenzoylbenzoate. That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 0.25.
- the content of each component in the dispersed phase component liquid is 20% by mass of monoglyceride stearate and 80% by mass of hexyl diethylaminohydroxybenzoylbenzoate. That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 4.
- the content of each component in the dispersed phase component liquid is 80 mass% for stearic acid monoglyceride and 20 mass% for dimethoxybenzylidene dioxoimidazolidine propionate. That is, the content ratio of the crystalline organic ultraviolet absorber to the solid fat is 0.25.
- Example 8 Except that propylene glycol monostearate was used as the solid fat, hydrogel particles having the same structure as in Example 6 were produced, and this was designated as Example 8.
- Example 9 A hydrogel particle having the same structure as that of Example 6 was prepared except that propylene glycol monobehenate was used as the solid fat.
- Example 5 A hydrogel particle having the same structure as in Example 7 was prepared except that lauric acid monoglyceride was used as the solid fat, and this was designated as Comparative Example 5.
- Behenyl alcohol was used as the solid fat, and the content in the resulting hydrogel particles was 21.6% by weight of behenyl alcohol and octyl dimethoxybenzylidene dioxoimidazolidine propionate. As a result, it was not possible to prepare a dispersed phase component liquid.
- the state of the hydrogel particles in the dispersed phase was observed using a CCD (KEYENCE manufactured by DIGITAL MICROSCOPE VHX-500), and the crystalline organic ultraviolet absorber crystals were observed. The presence or absence of precipitation was confirmed. And it is judged that there is crystal precipitation when it is observed that the crystalline organic ultraviolet absorber grows into coarse needle-like crystals of 50 ⁇ m or more in the dispersed phase, while there is no crystal precipitation when it is not observed. It was judged.
- hydrogel particles of Examples 1 to 3, 6, 8, and 9 and Comparative Example 4 were subjected to the same test evaluation when stored in a 5 ° C. atmosphere for 2 weeks.
- the hydrogel particles of Examples 1 to 3, 6, 8, and 9 and Comparative Examples 1 and 4 were subjected to the same test evaluation when stored in a 40 ° C. atmosphere for 2 weeks.
- Test evaluation results The test evaluation results are shown in Tables 1 and 2.
- the volume-based average particle diameter was 150 ⁇ m in all of Examples 1 to 5 and 7 to 9 and Comparative Examples 1 to 3 and 5, 176 ⁇ m in Example 6, and 161 ⁇ m in Comparative Example 4.
- Example 10 About the hydrogel particles of Example 1, 50% by mass of hydrogel particles, 0.2% by mass of phenoxyethanol (trade name: Hisolv EPH manufactured by Toho Chemical Co., Ltd.), 10.00% by mass of ethanol, and 39.8% by mass of purified water A slurry having a composition ratio was prepared. This slurry was mixed with a cosmetic base listed in Table 4 to prepare an ultraviolet protective cosmetic in order to examine its suitability for use in an ultraviolet protective cosmetic.
- hydrogel particle slurry 20% by mass, 2-methoxyhexyl paramethoxycinnamate (trade name: Ubinal MC80 manufactured by BASF) 8.5% by mass, dimethicone (trade name: Silicone KF- manufactured by Shin-Etsu Chemical Co., Ltd.) 96A (10cs)) 1.0% by mass, acrylic acid copolymer (manufactured by Nikko Chemicals Co., Ltd., trade name: Carbopol ETD2020) 0.1% by mass, acrylic acid-alkyl methacrylate copolymer (manufactured by Nikko Chemicals Co., Ltd.) : PEMULEN TR-2) 0.2% by mass, acrylic acid-alkyl methacrylate copolymer (product name: PEMULEN TR-1) 0.2% by mass, phenoxyethanol (product of Toho Chemical Industry Co., Ltd.) Hisolv EPH) 0.4% by mass, liquid caustic potash (48%) 0.36% by mass, eta Lum
- the present invention is useful for hydrogel particles and methods for producing the same.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
本実施形態に係るハイドロゲル粒子は、例えば、化粧品、医薬品、医薬部外品等に配合されて用いられるものであり、非架橋型ハイドロゲルの連続相とその連続相内に分散した分散相とを備え、そして、分散相が、有機概念図における有機性値(OV)が310以上で且つ無機性値(IV)が130以上である固体脂と結晶性有機系紫外線吸収剤とを含有し、また、結晶性有機系紫外線吸収剤の分散相における含有量が15~70質量%である。
連続相は、水性成分の非架橋型ハイドロゲルで構成されており、ゲル形成剤と水とを含む。
ゲル形成剤としては、例えば、寒天、カラギーナン、ゼラチン等が挙げられる。これらのうち寒天が好ましい。ゲル形成剤は、単一種で構成されていてもよく、また、複数種で構成されていてもよい。
分散相は、固体脂を含む油性成分と結晶性有機系紫外線吸収剤とを含有する。
油性成分は固体脂を含むが、固体脂だけで構成されていてもよく、また、液体油を併せて含んでいてもよい。ここで、本出願における「固体脂」とは、融点が35℃以上の油性成分をいう。また、本出願における「液体油」とは、融点が35℃未満の油性成分をいう。なお、固体脂や液体油の融点は、示差走査熱量測定法(DSC:Differential Scanning Calorimentry)によって測定することができる。
固体脂は、有機概念図における有機性値(OV)が310以上で且つ無機性値(IV)が130以上の固体脂(以下、「固体脂A」という。)を含む。
(式中、nは1~4の数であり、X及びYは、各々独立して、H、OH、OCOR2、又はOCO(CH2)2COOHであり、R1及びR2は、各々独立して、炭素数13~21のいずれかの直鎖飽和炭化水素基である。)。
液体油としては、例えば、液体の皮膚保護剤、液体の紫外線吸収剤、液体の油剤、液体の香料等が挙げられる。
本明細書において、「結晶性」とは、X線回折によりピークを有し、結晶状態を確認できることを意味する。また、「有機系紫外線吸収剤」とは、波長領域が280~400nmの範囲の紫外線、特に波長領域が320~400nmのUVAを吸収する性能を発現し、チタンや亜鉛等の無機物を含まない化合物を意味し、紫外線吸収能の有無は、例えば、SPFアナライザーなどの装置を用いて確認することができる。
連続相は、非架橋型ハイドロゲルのゲル化剤及び水以外に、特開2000-126586号公報に記載の糖類、多価アルコール、水溶性高分子化合物、水溶性香料等の水溶性有機化合物の成分を含有してもよい。
次に、本実施形態に係るハイドロゲル粒子の製造方法について説明する。
まず、連続相成分液として水性成分のゲル形成剤及びイオン交換水を混合し、その溶解温度以上の温度に加熱して十分に溶解させた混合液Aを調製する。一方、分散相成分液として油性成分及び結晶性有機系紫外線吸収剤を加熱混合して十分に溶解させた混合液Bを調製する。このとき、製造するハイドロゲル粒子の分散相における結晶性有機系紫外線吸収剤の含有量が15~70質量%となるように分散相成分液を調製する。
続いて、水中油型分散液を調製した後、その水中油型分散液から一般的な滴下法、噴霧法、或いは、攪拌法によりハイドロゲル粒子を製造する。但し、ハイドロゲル粒子からの油性成分の漏出を抑制する観点から、攪拌法よりも滴下法、或いは、噴霧法で製造することが好ましい。
上記のハイドロゲル粒子を配合することにより、紫外線防御効果を有する紫外線防御化粧料を得ることができる。その場合、w/o型、o/w型のいずれの化粧料にも適用することが可能であるが、o/w型の化粧料に用いることが好ましい。
(ハイドロゲル粒子)
以下の実施例1~9及び比較例1~5のハイドロゲル粒子を調製した。それぞれの構成は表1及び2にも示す。
油性成分の固体脂としてステアリン酸モノグリセライド(花王社製 商品名:レオドールMS-60、OV=564、IV=244、IOB値=0.43、HLB値=4.3)、及び結晶性有機系紫外線吸収剤としてジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル(BASFジャパン社製 商品名:ユビナールAplus、OV=480、IV=325、IOB値=0.68、HLB値=6.77)を含む分散相成分液を調製した。このとき、得られるハイドロゲル粒子における含有量が、ステアリン酸モノグリセライド13.5質量%、及びジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル13.5質量%となるように配合を行った。各成分の分散相成分液における含有量は、ステアリン酸モノグリセライドが50質量%、及びジエチルアミノヒドロキシベンゾイル安息香酸ヘキシルが50質量%である。つまり、結晶性有機系紫外線吸収剤の固体脂に対する含有量比は1である。なお、花王社製 商品名:レオドールMS-60はステアリン酸モノグリセライドを主成分とする固体脂である。
油性成分の固体脂としてモノステアリン酸プロピレングリコール(太陽化学社製 商品名:サンソフトNo.25CD、OV=420、IV=160、IOB値=0.38、HLB値=3.8)を用いたことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを実施例2とした。
油性成分の固体脂としてモノベヘニン酸プロピレングリコール(理研ビタミン社製 商品名:リケマールPB-100、OV=500、IV=160、IOB値=0.32、HLB値=3.2)を用いたことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを実施例3とした。
油性成分の固体脂としてステアリン酸モノグリセライドと共にステアリン酸モノグリセライドコハク酸エステル(花王社製 商品名:ステップSS、OV=500、IV=380、IOB値=0.76、HLB値=7.6)を用い、得られるハイドロゲル粒子における含有量が、ステアリン酸モノグリセライド10.5質量%及びステアリン酸モノグリセライドコハク酸エステル3.0質量%となるように配合を行ったことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを実施例4とした。
油性成分の固体脂としてステアリン酸モノグリセライドを用いると共に、液体油としてパラメトキシケイ皮酸オクチル(BASFジャパン社製 商品名:ユビナールMC80)を用い、得られるハイドロゲル粒子における含有量が、ステアリン酸モノグリセライド9.0質量%及びパラメトキシケイ皮酸オクチル4.5質量%となるように配合を行ったことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを実施例5とした。
得られるハイドロゲル粒子における含有量が、ステアリン酸モノグリセライド10.8質量%、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル16.2質量%となるように配合を行ったことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを実施例6とした。なお、各成分の分散相成分液における含有量は、ステアリン酸モノグリセライド40質量%、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル60質量%である。つまり、結晶性有機系紫外線吸収剤の固体脂に対する含有量比は1.5である。
固体脂としてベヘニルアルコール(花王社製 商品名:カルコール220-80、OV=440、IV=100、IOB値=0.23、HLB値=2.3)を用いたことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを比較例1とした。
固体脂としてラウリン酸モノグリセライド(太陽化学社製 商品名:サンソフトNo.750、OV=300、IV=260、IOB値=0.87、HLB値=8.7)を用い、得られるハイドロゲル粒子における含有量が、ラウリン酸モノグリセライド21.6質量%及びジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル5.4質量%となるように配合を行ったことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを比較例2とした。
固体脂としてエチレングリコールジステアレート(東邦化学社製 商品名:ペグノールEDS、OV=760、IV=120、IOB値=0.16、HLB値=1.6)を用いたことを除いて比較例2と同一構成のハイドロゲル粒子を作製し、これを比較例3とした。
得られるハイドロゲル粒子における含有量が、ステアリン酸モノグリセライド5.4質量%、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル21.6質量%となるように配合を行ったことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを比較例4とした。なお、各成分の分散相成分液における含有量は、ステアリン酸モノグリセライド20質量%、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル80質量%である。つまり、結晶性有機系紫外線吸収剤の固体脂に対する含有量比は4である。
結晶性有機系紫外線吸収剤としてジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル(味の素社製 商品名:ソフトシェードDH、OV=460、IV=462、IOB値=1.00、HLB値=10.04)を用い、得られるハイドロゲル粒子における含有量が、ステアリン酸モノグリセライド21.6質量%及びジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル5.4質量%となるように配合を行ったことを除いて実施例1と同一構成のハイドロゲル粒子を作製し、これを実施例7とした。
固体脂としてモノステアリン酸プロピレングリコールを用いたことを除いて実施例6と同一構成のハイドロゲル粒子を作製し、これを実施例8とした。
固体脂としてモノベヘニン酸プロピレングリコールを用いたことを除いて実施例6と同一構成のハイドロゲル粒子を作製し、これを実施例9とした。
固体脂としてラウリン酸モノグリセライドを用いたことを除いて実施例7と同一構成のハイドロゲル粒子を作製し、これを比較例5とした。
固体脂としてベヘニルアルコールを用い、得られるハイドロゲル粒子における含有量が、ベヘニルアルコール21.6質量%及びジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル5.4質量%となるように配合を行ったが、相溶しなかったため分散相成分液の調製を行うことはできなかった。
<体積基準平均粒径>
実施例1~9及び比較例1~5のそれぞれのハイドロゲル粒子について、レーザー回折/散乱式粒度分布測定装置(堀場製作所社製 型番:LA-920)を用いてメジアン径を測定し、それをハイドロゲル粒子の体積基準平均粒径とした。
実施例1~9及び比較例1~5のそれぞれのハイドロゲル粒子について、表3に示すように、ハイドロゲル粒子50質量%、フェノキシエタノール(東邦化学社製 商品名:ハイソルブEPH)0.2質量%、エタノール8.31質量%、及び精製水41.49質量%の組成比となるスラリーを調製した。
試験評価結果を表1及び2に示す。
(紫外線防御化粧料)
<実施例10>
実施例1のハイドロゲル粒子について、ハイドロゲル粒子50質量%、フェノキシエタノール(東邦化学社製 商品名:ハイソルブEPH)0.2質量%、エタノール10.00質量%、及び精製水39.8質量%の組成比となるスラリーを調製した。このスラリーについて、紫外線防御化粧料への使用適性を調べるべく、表4に記載の化粧料基剤と混合して紫外線防御化粧料を調製し、これを実施例10とした。
表4に記載の化粧料基剤を混合して紫外線防御化粧料を調製し、これを比較例6とした。
<実使用試験>
実施例10及び比較例6のそれぞれの紫外線防御化粧料について、専門パネラー3名が前腕部に塗布し、使用時のみずみずしさに関する実使用試験を行った。そして、下記評価基準で3人の平均スコアを求めた。
スコア5・・・みずみずしい
スコア4・・・ややみずみずしい
スコア3・・・どちらともいえない
スコア2・・・ややみずみずしくない
スコア1・・・みずみずしくない
<保存安定性試験>
実施例10及び比較例6のそれぞれの紫外線防御化粧料について、50℃の温度雰囲気下で1ヶ月静置保管後の分離の有無を目視で確認し、以下の基準で評価を行った。
実施例10及び比較例6のそれぞれの紫外線防御化粧料について、200mLビーカーに200mL入れ、攪拌機で回転数を10rpmとして60分間攪拌した後の分離の有無を目視で確認し、以下の基準で評価を行った。
B:やや分離あり
C:分離あり
(試験評価結果)
表4に試験評価結果を示す。
Claims (11)
- 非架橋型ハイドロゲルの連続相と、該連続相内に分散した分散相と、を備え、
上記分散相は、有機概念図における有機性値が310以上で且つ無機性値が130以上である固体脂と、結晶性有機系紫外線吸収剤と、を含有し、
上記結晶性有機系紫外線吸収剤は、上記分散相における含有量が15~70質量%である、ハイドロゲル粒子。 - 上記固体脂の有機概念図における有機性値が310~1000で且つ無機性値が130~800である、請求項1に記載のハイドロゲル粒子。
- 上記固体脂の有機概念図における有機性値(OV)に対する無機性値(IV)の比(IV/OV)が0.20~1.10である、請求項1又は2に記載のハイドロゲル粒子。
- 上記結晶性有機系紫外線吸収剤の有機概念図における有機性値が310~800で且つ無機性値が130~700である、請求項1~3の何れかに記載のハイドロゲル粒子。
- 上記結晶性有機系紫外線吸収剤の有機概念図における有機性値(OV)に対する無機性値(IV)の比(IV/OV)が0.30~1.1である、請求項1~4の何れかに記載のハイドロゲル粒子。
- 上記固体脂が、下記一般式(1)で表される化合物である、請求項1~5の何れかに記載のハイドロゲル粒子。
R1COOCH2(CHX)nCH2Y (1)
(式中、nは1~4の数であり、X及びYは、各々独立して、H、OH、OCOR2、又はOCO(CH2)2COOHであり、R1及びR2は、各々独立して、炭素数13~21のいずれかの直鎖飽和炭化水素基である。) - 上記固体脂は、脂肪酸グリセリンエステル類及び脂肪酸アルキレングリコールエステル類のうち少なくとも一方を含む、請求項1~6の何れかに記載のハイドロゲル粒子。
- 結晶性有機系紫外線吸収剤、有機概念図における有機性値が310以上で且つ無機性値が130以上である固体脂、ゲル形成剤、及び水を含む混合物を、滴下、噴霧、又は攪拌することにより、該ゲル形成剤及び該水を含有する非架橋型ハイドロゲルの連続相内に、該結晶性有機系紫外線吸収剤及び該固体脂を含有する分散相が分散したハイドロゲル粒子を製造する方法であって、
上記混合物を、製造するハイドロゲル粒子の分散相における結晶性有機系紫外線吸収剤の含有量が15~70質量%となるように調製するハイドロゲル粒子の製造方法。 - 上記混合物を、上記ゲル形成剤のゲル化温度以上で混合することにより調製する、請求項8に記載のハイドロゲル粒子の製造方法。
- 上記混合物を、上記ゲル形成剤及び水を含む混合物Aと、上記結晶性有機系紫外線吸収剤及び固体脂を含む混合物Bとを、上記ゲル形成剤のゲル化温度以上で混合することにより調製する、請求項9に記載のハイドロゲル粒子の製造方法。
- 請求項1~7の何れかに記載されたハイドロゲル粒子が配合された紫外線防御化粧料。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201080056838.2A CN102665652B (zh) | 2009-12-24 | 2010-12-16 | 水凝胶颗粒 |
EP10838914A EP2517689A1 (en) | 2009-12-24 | 2010-12-16 | Hydrogel particles |
US13/519,002 US8652448B2 (en) | 2009-12-24 | 2010-12-16 | Hydrogel particles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009-293119 | 2009-12-24 | ||
JP2009293119 | 2009-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011077674A1 true WO2011077674A1 (ja) | 2011-06-30 |
Family
ID=44195228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2010/007306 WO2011077674A1 (ja) | 2009-12-24 | 2010-12-16 | ハイドロゲル粒子 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8652448B2 (ja) |
EP (1) | EP2517689A1 (ja) |
JP (1) | JP5190505B2 (ja) |
CN (1) | CN102665652B (ja) |
TW (1) | TWI454310B (ja) |
WO (1) | WO2011077674A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013194033A (ja) * | 2012-03-22 | 2013-09-30 | Kao Corp | 化粧料 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5917043B2 (ja) * | 2011-08-15 | 2016-05-11 | 花王株式会社 | 皮膚外用剤 |
JP6092665B2 (ja) * | 2012-03-15 | 2017-03-08 | 花王株式会社 | ハイドロゲル粒子 |
BR112015028140B1 (pt) * | 2013-05-10 | 2020-10-13 | Basf Se | agente altamente concentrado, método para uma preparação de formulações finais de protetores solares, e, uso de um agente |
JP6180254B2 (ja) * | 2013-09-24 | 2017-08-16 | 花王株式会社 | ハイドロゲル粒子 |
CA2959817A1 (en) | 2014-09-10 | 2016-03-17 | The Procter & Gamble Company | Nonwoven web |
EP3215085B1 (en) | 2014-11-06 | 2019-10-09 | The Procter and Gamble Company | Crimped fiber spunbond nonwoven webs / laminates |
JP6580907B2 (ja) * | 2014-11-20 | 2019-09-25 | 花王株式会社 | 皮膚化粧料 |
JP6321722B2 (ja) | 2015-05-29 | 2018-05-09 | 花王株式会社 | ハイドロゲル粒子の製造方法 |
JP7032917B2 (ja) * | 2016-12-08 | 2022-03-09 | 花王株式会社 | ハイドロゲル粒子 |
KR102179649B1 (ko) * | 2019-10-11 | 2020-11-18 | (주)에이에스텍 | 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법 |
US20230372223A1 (en) * | 2020-10-29 | 2023-11-23 | Japan Coating Resin Corporation | Method for manufacturing composition |
CN117396175A (zh) * | 2021-05-31 | 2024-01-12 | 花王株式会社 | 皮肤外用剂 |
TWI873425B (zh) * | 2021-05-31 | 2025-02-21 | 日商花王股份有限公司 | 皮膚外用劑及其製造方法 |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07100356A (ja) | 1993-09-30 | 1995-04-18 | Shiseido Co Ltd | 新規複合体及び乳化剤 |
JPH08252447A (ja) | 1995-03-20 | 1996-10-01 | Shiseido Co Ltd | 水溶性両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH09141079A (ja) | 1995-11-15 | 1997-06-03 | Shiseido Co Ltd | 水溶性両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH09141080A (ja) | 1995-11-15 | 1997-06-03 | Shiseido Co Ltd | 水溶性架橋型両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH09141081A (ja) | 1995-11-15 | 1997-06-03 | Shiseido Co Ltd | 水溶性架橋型両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH1053625A (ja) | 1996-06-05 | 1998-02-24 | Shiseido Co Ltd | アクリル酸系ポリマー及びこれを配合した乳化組成物 |
JPH10330401A (ja) | 1997-05-30 | 1998-12-15 | Kao Corp | 新規多糖誘導体及びその製造方法 |
JPH11106401A (ja) | 1997-10-07 | 1999-04-20 | Kao Corp | 新規多糖誘導体及びその製造方法 |
JP2000126586A (ja) | 1998-10-27 | 2000-05-09 | Kao Corp | カプセル粒子の水分除去方法 |
JP2001096146A (ja) * | 1999-07-27 | 2001-04-10 | Shiseido Co Ltd | マイクロカプセル及びその製造方法 |
EP1172083A2 (en) * | 2000-06-30 | 2002-01-16 | Kao Corporation | Hydrogel matrix particles comprising a dispersed lipophilic component, process of preparation and skin cosmetic composition containing hydrogel particles |
JP2002020227A (ja) | 2000-06-30 | 2002-01-23 | Kao Corp | 皮膚化粧料 |
JP2002037713A (ja) * | 2000-07-21 | 2002-02-06 | Lion Corp | 紫外線吸収剤内包マイクロカプセルおよびそれを用いた化粧料 |
JP2002159838A (ja) | 2000-08-14 | 2002-06-04 | Kao Corp | ハイドロゲル粒子 |
JP3329689B2 (ja) | 1997-04-21 | 2002-09-30 | 花王株式会社 | 新規多糖誘導体及びその製造方法 |
JP2003238693A (ja) * | 2002-02-15 | 2003-08-27 | Kao Corp | ハイドロゲル粒子 |
JP2003252722A (ja) * | 2002-02-27 | 2003-09-10 | Kao Corp | ハイドロゲル粒子 |
JP2004107306A (ja) * | 2002-09-20 | 2004-04-08 | Kao Corp | 皮膚化粧料 |
JP2006225311A (ja) | 2005-02-17 | 2006-08-31 | Kao Corp | ジェル状化粧料 |
WO2010061556A1 (ja) * | 2008-11-28 | 2010-06-03 | 花王株式会社 | ハイドロゲル粒子 |
JP2010275269A (ja) * | 2009-06-01 | 2010-12-09 | Kao Corp | ハイドロゲル粒子 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391288B1 (en) | 1999-07-27 | 2002-05-21 | Shiseido Co., Ltd. | Microcapsule and method of making the same |
AU2006274133A1 (en) * | 2005-07-25 | 2007-02-01 | Basf Se | Dermocosmetic preparations |
JP4721888B2 (ja) | 2005-12-07 | 2011-07-13 | 花王株式会社 | ハイドロゲル粒子 |
JP4823675B2 (ja) | 2005-12-16 | 2011-11-24 | 花王株式会社 | ハイドロゲル粒子の製造方法、並びに、それによって製造されるハイドロゲル粒子及びそれを用いた分散体 |
JP4901344B2 (ja) * | 2006-07-12 | 2012-03-21 | 花王株式会社 | 油性粒子及びその製造方法 |
JP5352064B2 (ja) * | 2007-06-06 | 2013-11-27 | 花王株式会社 | ハイドロゲル粒子 |
DE102007035567A1 (de) * | 2007-07-26 | 2009-01-29 | Basf Se | UV-Filter-Kapsel |
DE102008051007A1 (de) * | 2008-10-13 | 2010-04-15 | Beiersdorf Ag | Polyamid-5-Verbindungen in kosmetischen Zubereitungen |
-
2010
- 2010-12-16 CN CN201080056838.2A patent/CN102665652B/zh active Active
- 2010-12-16 WO PCT/JP2010/007306 patent/WO2011077674A1/ja active Application Filing
- 2010-12-16 US US13/519,002 patent/US8652448B2/en not_active Expired - Fee Related
- 2010-12-16 EP EP10838914A patent/EP2517689A1/en not_active Withdrawn
- 2010-12-16 JP JP2010280463A patent/JP5190505B2/ja active Active
- 2010-12-21 TW TW099145025A patent/TWI454310B/zh active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07100356A (ja) | 1993-09-30 | 1995-04-18 | Shiseido Co Ltd | 新規複合体及び乳化剤 |
JPH08252447A (ja) | 1995-03-20 | 1996-10-01 | Shiseido Co Ltd | 水溶性両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH09141079A (ja) | 1995-11-15 | 1997-06-03 | Shiseido Co Ltd | 水溶性両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH09141080A (ja) | 1995-11-15 | 1997-06-03 | Shiseido Co Ltd | 水溶性架橋型両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH09141081A (ja) | 1995-11-15 | 1997-06-03 | Shiseido Co Ltd | 水溶性架橋型両親媒性高分子電解質からなる乳化剤、これを配合した乳化組成物及び乳化化粧料 |
JPH1053625A (ja) | 1996-06-05 | 1998-02-24 | Shiseido Co Ltd | アクリル酸系ポリマー及びこれを配合した乳化組成物 |
JP3329689B2 (ja) | 1997-04-21 | 2002-09-30 | 花王株式会社 | 新規多糖誘導体及びその製造方法 |
JPH10330401A (ja) | 1997-05-30 | 1998-12-15 | Kao Corp | 新規多糖誘導体及びその製造方法 |
JPH11106401A (ja) | 1997-10-07 | 1999-04-20 | Kao Corp | 新規多糖誘導体及びその製造方法 |
JP2000126586A (ja) | 1998-10-27 | 2000-05-09 | Kao Corp | カプセル粒子の水分除去方法 |
JP2001096146A (ja) * | 1999-07-27 | 2001-04-10 | Shiseido Co Ltd | マイクロカプセル及びその製造方法 |
EP1172083A2 (en) * | 2000-06-30 | 2002-01-16 | Kao Corporation | Hydrogel matrix particles comprising a dispersed lipophilic component, process of preparation and skin cosmetic composition containing hydrogel particles |
JP2002020227A (ja) | 2000-06-30 | 2002-01-23 | Kao Corp | 皮膚化粧料 |
JP2002037713A (ja) * | 2000-07-21 | 2002-02-06 | Lion Corp | 紫外線吸収剤内包マイクロカプセルおよびそれを用いた化粧料 |
JP2002159838A (ja) | 2000-08-14 | 2002-06-04 | Kao Corp | ハイドロゲル粒子 |
JP2003238693A (ja) * | 2002-02-15 | 2003-08-27 | Kao Corp | ハイドロゲル粒子 |
JP2003252722A (ja) * | 2002-02-27 | 2003-09-10 | Kao Corp | ハイドロゲル粒子 |
JP2004107306A (ja) * | 2002-09-20 | 2004-04-08 | Kao Corp | 皮膚化粧料 |
JP2006225311A (ja) | 2005-02-17 | 2006-08-31 | Kao Corp | ジェル状化粧料 |
WO2010061556A1 (ja) * | 2008-11-28 | 2010-06-03 | 花王株式会社 | ハイドロゲル粒子 |
JP2010275269A (ja) * | 2009-06-01 | 2010-12-09 | Kao Corp | ハイドロゲル粒子 |
Non-Patent Citations (2)
Title |
---|
"Techniques of Emulsification and Solubilization", 20 May 1984, KOUGAKUTOSHO LTD., pages: 8 - 12 |
YOSHIO KODA: "Organic Conceptual Diagram -basis and application", 1984, SANKYO PUBLISHING, pages: 13 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013194033A (ja) * | 2012-03-22 | 2013-09-30 | Kao Corp | 化粧料 |
Also Published As
Publication number | Publication date |
---|---|
US20120288457A1 (en) | 2012-11-15 |
TWI454310B (zh) | 2014-10-01 |
US8652448B2 (en) | 2014-02-18 |
JP2011148771A (ja) | 2011-08-04 |
EP2517689A1 (en) | 2012-10-31 |
CN102665652B (zh) | 2014-07-16 |
TW201127482A (en) | 2011-08-16 |
CN102665652A (zh) | 2012-09-12 |
JP5190505B2 (ja) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5190505B2 (ja) | ハイドロゲル粒子 | |
JP5632604B2 (ja) | ハイドロゲル粒子 | |
US8673326B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
TWI699216B (zh) | 皮膚化妝料 | |
JP5352064B2 (ja) | ハイドロゲル粒子 | |
US8287917B2 (en) | Hydrogel particle | |
CA2123717C (en) | Compositions containing particles of metallic oxide and hydrophilic organic sunscreen | |
JP2016526568A (ja) | オレオソームの形態のo/wエマルジョン形態の着色性組成物 | |
JP4901344B2 (ja) | 油性粒子及びその製造方法 | |
JP5827079B2 (ja) | 粉体含有皮膚外用剤 | |
JP5806478B2 (ja) | 皮膚外用剤 | |
JP2012171892A (ja) | 皮膚外用剤 | |
US20220001443A1 (en) | Powder dispersion composition and dispersing method thereof | |
JP7032917B2 (ja) | ハイドロゲル粒子 | |
JP6092665B2 (ja) | ハイドロゲル粒子 | |
TW201700089A (zh) | 具有高劑型穩定性的化妝品組合物 | |
WO2025069444A1 (en) | Water-in-oil emulsified cosmetic or anhydrous cosmetic and method for their production | |
TW202312978A (zh) | 皮膚外用劑 | |
JP2001220315A (ja) | 化粧料組成物 | |
GB2279007A (en) | Compositions containing sunscreens | |
JP2022021511A (ja) | 化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080056838.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10838914 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010838914 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1201003061 Country of ref document: TH |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13519002 Country of ref document: US |